おすすめの製品
グレード
certified reference material
pharmaceutical secondary standard
品質水準
認証
traceable to Ph. Eur. Y0000089
traceable to USP 1078518
APIファミリー
bupivacaine
CofA
current certificate can be downloaded
包装
pkg of 40 mg
アプリケーション
pharmaceutical (small molecule)
フォーマット
neat
保管温度
2-8°C
詳細
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Bupivacaine and its derivatives are a category of compounds that are used as local anesthetics. Its applications consist of infiltration, nerve block, epidural, and intrathecal anesthesia.
Bupivacaine and its derivatives are a category of compounds that are used as local anesthetics. Its applications consist of infiltration, nerve block, epidural, and intrathecal anesthesia.
アプリケーション
Bupivacaine may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by chromatographic and spectrophotometric techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
アナリシスノート
このような2次標準は、入手可能な場合にはUSP、EP、BPの1次標準にマルチトレーサビリティを提供します。
その他情報
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
脚注
To see an example of a Certificate of Analysis for this material enter LRAA7909 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
関連製品
製品番号
詳細
価格
シグナルワード
Danger
危険有害性情報
危険有害性の分類
Acute Tox. 3 Oral - Aquatic Chronic 4
保管分類コード
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK
WGK 3
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
PHR1738-40MG-PW:
PHR1738-40MG:
最新バージョンのいずれかを選択してください：
Protein synthesis in bupivacaine (Marcaine)-treated, regenerating skeletal muscle
Jones GH
Muscle and Nerve, 5(4), 281-290 (1982)
Bupivacaine decreases cell viability and matrix protein synthesis in an intervertebral disc organ model system
Wang D, et al.
The Spine Journal : Official Journal of the North American Spine Society, 11(2), 139-146 (2011)
Determination of tramadol, metamizole, ropivacaine, and bupivacaine in analgesic mixture samples by HPLC with DAD detection
Salmeron-Garcia A, et al.
Journal of Chromatographic Science, 47(3), 231237-231237 (2009)
Quantitative mass spectrometric analysis of ropivacaine and bupivacaine in authentic, pharmaceutical and spiked human plasma without chromatographic separation
Salama NN and Wang S
Analytical Chemistry Insights, 4(3), ACI-S2564 (2009)
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）